Global Life Science Tools & Reagents Market By Type (Tools, and Reagents), By Application (Proteomics, Cell biology research, Epigenetics, Metabolomics, and Bioinformatics), By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2019–2028
- Published date: May 2021
- Report ID: 22002
- Number of Pages: 207
- Format:
- keyboard_arrow_up
- 1. Life Science Tools & Reagents Market Introduction
- 1.1. Definition
- 1.2. Taxonomy
- 1.3. Research Scope
- 2. Executive Summary
- 2.1. Key Findings by Major Segments
- 2.2. Top strategies by Major Players
- 3. Global Life Science Tools & Reagents Market Overview
- 3.1. Life Science Tools & Reagents Market Dynamics
- 3.1.1. Drivers
- 3.1.2. Opportunities
- 3.1.3. Restraints
- 3.1.4. Challenges
- 3.2. PESTLE Analysis
- 3.3. Opportunity Map Analysis
- 3.4. PORTER'S Five Forces Analysis
- 3.5. Market Competition Scenario Analysis
- 3.6. Product Life Cycle Analysis
- 3.7. Opportunity Orbits
- 3.8. Manufacturer Intensity Map
- 3.1. Life Science Tools & Reagents Market Dynamics
- 4. Global Life Science Tools & Reagents Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
- 4.1. Global Life Science Tools & Reagents Market Analysis by Type: Introduction
- 4.2. Market Size and Forecast by Region
- 4.3. Tools
- 4.4. Reagents
- 5. Global Life Science Tools & Reagents Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
- 5.1. Global Life Science Tools & Reagents Market Analysis by Application: Introduction
- 5.2. Market Size and Forecast by Region
- 5.3. Proteomics
- 5.4. Cell biology research
- 5.5. Epigenetics
- 5.6. Metabolomics
- 5.7. Bioinformatics
- 6. Global Life Science Tools & Reagents Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
- 6.1. North America
- 6.1.1. North America Life Science Tools & Reagents Market: Regional Trend Analysis
- 6.1.1.1. US
- 6.1.1.2. Canada
- 6.1.1.3. Mexico
- 6.1.1. North America Life Science Tools & Reagents Market: Regional Trend Analysis
- 6.2. Europe
- 6.2.1. Europe Life Science Tools & Reagents Market: Regional Trend Analysis
- 6.2.1.1. Germany
- 6.2.1.2. France
- 6.2.1.3. UK
- 6.2.1.4. Russia
- 6.2.1.5. Italy
- 6.2.1.6. Rest of Europe
- 6.2.1. Europe Life Science Tools & Reagents Market: Regional Trend Analysis
- 6.3. Asia-Pacific
- 6.3.1. Asia-Pacific Life Science Tools & Reagents Market: Regional Trend Analysis
- 6.3.1.1. China
- 6.3.1.2. Japan
- 6.3.1.3. Korea
- 6.3.1.4. India
- 6.3.1.5. Rest of Asia
- 6.3.1. Asia-Pacific Life Science Tools & Reagents Market: Regional Trend Analysis
- 6.4. Latin America
- 6.4.1. Latin America Life Science Tools & Reagents Market: Regional Trend Analysis
- 6.4.1.1. Brazil
- 6.4.1.2. Argentina
- 6.4.1.3. Rest of Latin America
- 6.4.1. Latin America Life Science Tools & Reagents Market: Regional Trend Analysis
- 6.5. Middle East and Africa
- 6.5.1. Middle East and Africa Life Science Tools & Reagents Market: Regional Trend Analysis
- 6.5.1.1. GCC
- 6.5.1.2. South Africa
- 6.5.1.3. Israel
- 6.5.1.4. Rest of MEA
- 6.5.1. Middle East and Africa Life Science Tools & Reagents Market: Regional Trend Analysis
- 6.1. North America
- 7. Global Life Science Tools & Reagents Market Competitive Landscape, Market Share Analysis, and Company Profiles
- 7.1. Market Share Analysis
- 7.2. Company Profiles
- 7.3. Abbott Laboratories
- 7.3.1. Company Overview
- 7.3.2. Financial Highlights
- 7.3.3. Product Portfolio
- 7.3.4. SWOT Analysis
- 7.3.5. Key Strategies and Developments
- 7.4. Abcam
- 7.4.1. Company Overview
- 7.4.2. Financial Highlights
- 7.4.3. Product Portfolio
- 7.4.4. SWOT Analysis
- 7.4.5. Key Strategies and Developments
- 7.5. BD Biosciences
- 7.5.1. Company Overview
- 7.5.2. Financial Highlights
- 7.5.3. Product Portfolio
- 7.5.4. SWOT Analysis
- 7.5.5. Key Strategies and Developments
- 7.6. Beckman Coulter Inc.
- 7.6.1. Company Overview
- 7.6.2. Financial Highlights
- 7.6.3. Product Portfolio
- 7.6.4. SWOT Analysis
- 7.6.5. Key Strategies and Developments
- 7.7. Benitec
- 7.7.1. Company Overview
- 7.7.2. Financial Highlights
- 7.7.3. Product Portfolio
- 7.7.4. SWOT Analysis
- 7.7.5. Key Strategies and Developments
- 7.8. Bio-Rad Laboratories
- 7.8.1. Company Overview
- 7.8.2. Financial Highlights
- 7.8.3. Product Portfolio
- 7.8.4. SWOT Analysis
- 7.8.5. Key Strategies and Developments
- 7.9. Cell Sciences
- 7.9.1. Company Overview
- 7.9.2. Financial Highlights
- 7.9.3. Product Portfolio
- 7.9.4. SWOT Analysis
- 7.9.5. Key Strategies and Developments
- 7.10. Cell Signaling Technology
- 7.10.1. Company Overview
- 7.10.2. Financial Highlights
- 7.10.3. Product Portfolio
- 7.10.4. SWOT Analysis
- 7.10.5. Key Strategies and Developments
- 7.11. Cepheid Inc.
- 7.11.1. Company Overview
- 7.11.2. Financial Highlights
- 7.11.3. Product Portfolio
- 7.11.4. SWOT Analysis
- 7.11.5. Key Strategies and Developments
- 7.12. Charles River Laboratories International Inc.
- 7.12.1. Company Overview
- 7.12.2. Financial Highlights
- 7.12.3. Product Portfolio
- 7.12.4. SWOT Analysis
- 7.12.5. Key Strategies and Developments
- 7.13. Echelon Biosciences Inc.
- 7.13.1. Company Overview
- 7.13.2. Financial Highlights
- 7.13.3. Product Portfolio
- 7.13.4. SWOT Analysis
- 7.13.5. Key Strategies and Developments
- 7.14. Emd Millipore
- 7.14.1. Company Overview
- 7.14.2. Financial Highlights
- 7.14.3. Product Portfolio
- 7.14.4. SWOT Analysis
- 7.14.5. Key Strategies and Developments
- 7.15. Enzo Biochem
- 7.15.1. Company Overview
- 7.15.2. Financial Highlights
- 7.15.3. Product Portfolio
- 7.15.4. SWOT Analysis
- 7.15.5. Key Strategies and Developments
- 7.16. High Throughput Genomics Inc.
- 7.16.1. Company Overview
- 7.16.2. Financial Highlights
- 7.16.3. Product Portfolio
- 7.16.4. SWOT Analysis
- 7.16.5. Key Strategies and Developments
- 7.17. Illumina Inc.
- 7.17.1. Company Overview
- 7.17.2. Financial Highlights
- 7.17.3. Product Portfolio
- 7.17.4. SWOT Analysis
- 7.17.5. Key Strategies and Developments
- 7.18. Lifesensors Inc.
- 7.18.1. Company Overview
- 7.18.2. Financial Highlights
- 7.18.3. Product Portfolio
- 7.18.4. SWOT Analysis
- 7.18.5. Key Strategies and Developments
- 7.19. Lonza Group AG
- 7.19.1. Company Overview
- 7.19.2. Financial Highlights
- 7.19.3. Product Portfolio
- 7.19.4. SWOT Analysis
- 7.19.5. Key Strategies and Developments
- 7.20. Luminex Corp.
- 7.20.1. Company Overview
- 7.20.2. Financial Highlights
- 7.20.3. Product Portfolio
- 7.20.4. SWOT Analysis
- 7.20.5. Key Strategies and Developments
- 7.21. Stemgent
- 7.21.1. Company Overview
- 7.21.2. Financial Highlights
- 7.21.3. Product Portfolio
- 7.21.4. SWOT Analysis
- 7.21.5. Key Strategies and Developments
- 7.22. Sysmex-Partec Gmbh
- 7.22.1. Company Overview
- 7.22.2. Financial Highlights
- 7.22.3. Product Portfolio
- 7.22.4. SWOT Analysis
- 7.22.5. Key Strategies and Developments
- 8. Assumptions and Acronyms
- 9. Research Methodology
- 10. Contact
- 1. Life Science Tools & Reagents Market Introduction
- Abbott Laboratories
- Abcam
- BD Biosciences
- Beckman Coulter Inc.
- Benitec
- Bio-Rad Laboratories, Inc. Company Profile
- Cell Sciences
- Cell Signaling Technology
- Cepheid Inc.
- Charles River Laboratories International Inc.
- Echelon Biosciences Inc.
- Emd Millipore
- Enzo Biochem
- High Throughput Genomics Inc.
- Illumina Inc.
- Lifesensors Inc.
- Lonza Group AG Company Profile
- Luminex Corp.
- Stemgent
- Sysmex-Partec Gmbh
- settingsSettings
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible
Single User
$5,999
$2,999
USD / per unit
save 50% |
Multi User
$7,999
$3,499
USD / per unit
save 55% |
Corporate User
$12,999
$4,499
USD / per unit
save 65% | |
---|---|---|---|
e-Access | |||
Data Set (Excel) | |||
Company Profile Library Access | |||
Interactive Dashboard | |||
Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
Accessibility | 1 User | 2-5 User | Unlimited |
Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
Buy Now ($ 2,999) | Buy Now ($ 3,499) | Buy Now ($ 4,499) |